KIN Historical PE Ratio image   This KIN PE ratio history page last updated 9/22/2021
KIN Historical PE Ratio Chart
Data adjusted for KIN split history

PeriodPriceGAAPAnnualizedPE
Q2 2021
8/5/2021
9.22-0.20-0.80NA
Q1 2021
5/11/2021
4.43-0.24-0.96NA
Q4 2020
3/16/2021
4.94-0.28-1.12NA
Q3 2020
11/9/2020
3.77-0.31-1.24NA
Q2 2020
8/5/2020
3.750.602.401.6
Q1 2020
5/7/2020
4.53-0.45-1.80NA
Q4 2019
3/16/2020
6.01-0.40-1.60NA
Q3 2019
11/12/2019
8.28-0.39-1.56NA
Q2 2019
8/1/2019
6.96-0.37-1.48NA
Q1 2019
5/9/2019
8.97-0.42-1.68NA
Q4 2018
3/6/2019
10.75-0.46-1.84NA
Q3 2018
11/7/2018
14.59-0.39-1.56NA
Q2 2018
8/9/2018
13.80-0.39-1.56NA
Q1 2018
5/8/2018
9.70-0.36-1.44NA
Q4 2017
3/1/2018
8.90-0.35-1.40NA
Q3 2017
11/7/2017
7.60-0.29-1.16NA
Q2 2017
8/7/2017
7.35-0.29-1.16NA
Q1 2017
5/3/2017
6.95-0.30-1.20NA
Q4 2016
3/1/2017
5.35-0.29-1.16NA
Q3 2016
11/7/2016
5.10-0.29-1.16NA
Q2 2016
8/8/2016
3.96-0.25-1.00NA
Q1 2016
5/5/2016
3.36-0.31-1.24NA
Q4 2015
3/2/2016
3.81-0.32-1.28NA
Q3 2015
11/9/2015
5.53-0.36-1.44NA
Q2 2015
8/10/2015
6.06-0.35-1.40NA
Q1 2015
5/8/2015
7.10-0.34-1.36NA
Q4 2014
3/12/2015
6.86-0.34-1.36NA
Q3 2014
11/13/2014
8.98-0.31-1.24NA
Q2 2014
8/13/2014
15.82-0.42-1.68NA
Q1 2014
5/12/2014
16.63-0.38-1.52NA
KIN PE History Chart
PeriodPriceGAAPTTMPE
Q2 2021
8/5/2021
9.22-0.20-1.03NA
Q1 2021
5/11/2021
4.43-0.24-0.23NA
Q4 2020
3/16/2021
4.94-0.28-0.44NA
Q3 2020
11/9/2020
3.77-0.31-0.56NA
Q2 2020
8/5/2020
3.750.60-0.64NA
Q1 2020
5/7/2020
4.53-0.45-1.61NA
Q4 2019
3/16/2020
6.01-0.40-1.58NA
Q3 2019
11/12/2019
8.28-0.39-1.64NA
Q2 2019
8/1/2019
6.96-0.37-1.64NA
Q1 2019
5/9/2019
8.97-0.42-1.66NA
Q4 2018
3/6/2019
10.75-0.46-1.60NA
Q3 2018
11/7/2018
14.59-0.39-1.49NA
Q2 2018
8/9/2018
13.80-0.39-1.39NA
Q1 2018
5/8/2018
9.70-0.36-1.29NA
Q4 2017
3/1/2018
8.90-0.35-1.23NA
Q3 2017
11/7/2017
7.60-0.29-1.17NA
Q2 2017
8/7/2017
7.35-0.29-1.17NA
Q1 2017
5/3/2017
6.95-0.30-1.13NA
Q4 2016
3/1/2017
5.35-0.29-1.14NA
Q3 2016
11/7/2016
5.10-0.29-1.17NA
Q2 2016
8/8/2016
3.96-0.25-1.24NA
Q1 2016
5/5/2016
3.36-0.31-1.34NA
Q4 2015
3/2/2016
3.81-0.32-1.37NA
Q3 2015
11/9/2015
5.53-0.36-1.39NA
Q2 2015
8/10/2015
6.06-0.35-1.34NA
Q1 2015
5/8/2015
7.10-0.34-1.41NA
Q4 2014
3/12/2015
6.86-0.34-1.45NA
Q3 2014
11/13/2014
8.98-0.31NANA
Q2 2014
8/13/2014
15.82-0.42NANA
Q1 2014
5/12/2014
16.63-0.38NANA
Quotes delayed 20 minutes
Get Free SEC filing alerts for KIN:
KIN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kindred Biosciences (KIN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KMPH PE Ratio History
KPTI PE Ratio History
KRYS PE Ratio History
KURA PE Ratio History
LCI PE Ratio History
LGND PE Ratio History
LH PE Ratio History
LHCG PE Ratio History
LIFE PE Ratio History
LJPC PE Ratio History
On this page we presented the KIN Historical PE Ratio information for Kindred Biosciences' stock. The average KIN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculationg the "E" value at each measurement period, the average KIN historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KIN historical PE result, against the recent PE: when this page was posted on 8/27/2021, the most recent closing price for KIN had been 9.25, and the most recent quarterly earnings result, annualized, was 2.4. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent KIN PE on 8/27/2021 based on annualized quarterly EPS was 3.9. Based on KIN's history, that recent PE is elevated relative to the historical average, with the recent PE 143.8% higher than the historical average PE across our data set for Kindred Biosciences.

For self directed investors doing their due diligence on KIN or any other given stock, valuation analysis for KIN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Kindred Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KIN. Thanks for visiting, and the next time you need to research KIN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.
 

KIN Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.